PICTET ASSET MANAGEMENT SA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT SA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$489,214
-6.3%
5,746
-8.9%
0.00%0.0%
Q1 2023$521,904
+105122.6%
6,3070.0%0.00%0.0%
Q4 2022$496
-99.8%
6,307
+67.1%
0.00%
Q3 2022$279,000
+13.4%
3,7750.0%0.00%
Q2 2022$246,000
+2.9%
3,7750.0%0.00%
Q1 2022$239,000
+19.5%
3,7750.0%0.00%
Q4 2021$200,000
-24.8%
3,7750.0%0.00%
Q3 2021$266,0003,7750.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders